Growth pitch: These 5 companies#39; sales, profit rose at least 25% in last 3 fiscal years
Interestingly, all these companies have gained at least 30 percent during the current fiscal (FY21) so far
Latest News from Moneycontrol.com
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




